The inflammation of the knee joints is known as osteoarthritis or degenerative arthritis of the knee. It is a wear-and-tear kind, degenerative arthritis that primarily affects people over the age of 50 years, although it can also affect people younger than that.
The inflammation of the knee joints is known as osteoarthritis or degenerative arthritis of the knee. It is a wear-and-tear kind, degenerative arthritis that primarily affects people over the age of 50 years, although it can also affect people younger than that. Knee osteoarthritis causes the cartilage in the knee joint to gradually wear away. As the cartilage wears away, the protecting area between the bones shrinks, causing the knee joint to become ragged and coarse.
Read Report Overview - https://www.transparencymarketresearch.com/knee-osteoarthritis-treatment-market.html
Friction between the bones occurs, resulting in painful bone spurs. Repetitive stress injuries, heavy and strenuous occupations, age, weight gain, hereditary abnormalities, and other conditions such as metabolic problems and rheumatoid arthritis are some of the most prevalent causes of this ailment. Knee stiffness, warmth in the joint, swelling, and decreased mobility are all symptoms of this disorder. Increased prevalence of the condition is expected to drive growth of the global knee osteoarthritis treatment market in the years to come.
The increased desire for minimally invasive surgical treatments, rising prevalence of osteoarthritis, and expanding base of geriatric population are likely to drive the global osteoarthritis treatment market. The increased incidences of knee osteoarthritis amongst general population reported across the world is a major factor driving market growth.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52047
Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.
The prominent factor contributing to the growth of the knee osteoarthritis is the rising prevalence of the condition among the general population observed across the globe. According to the Global Burden of Disease Study, in 2010, knee osteoarthritis accounted for 80% of the total osteoarthritis burden. Osteoarthritis is a common joint disease and a major cause of disability and chronic pain in the U.S and other developed countries. According to the data provided by the U.S. Centers for Disease Control and Prevention (CDC) in 2015, an estimated 15 million people reported of severe joint pain. with knee joint pain being the most prominent condition. The number of cases are expected to increase further in the next few years. This, in turn, is expected to drive the demand for therapies and medications used in the treatment of this condition.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=52047
Surge in geriatric population is expected to drive the knee osteoarthritis treatment market during the forecast period. Severity and incidence of knee joint pain caused due osteoarthritis increases with age. According to United Nations’ World Population Ageing report, the number of people above the age of 60 years stood at 962 million in 2017, which is projected to reach 2.1 billion by 2050. Rise in geriatric population is anticipated to increase the number of individuals suffering from knee osteoarthritis, which is expected to drive the demand for medications & therapies used to manage these conditions.
Pharmaceutical companies launching new products launches to provide improved treatment options to people suffering from knee osteoarthritis. In March 2018, Bioventus, a leading global provider of orthobiologic solutions launched DUROLANE, a hyaluronic acid (HA) single-injection product deployed for joint lubrication. It is used in the management of pain caused due to knee osteoarthritis in the U.S. DUROLANE joins the company existing knee osteoarthritis products GELSYN-3, a three-injection HA product launched in 2016 and SUPARTZ FX, a five-injection HA launched in 2015. In May 2016, Anika Therapeutics, Inc., an integrated orthopedics medicines company launched CINGAL, the company’s 3rd generation viscosupplement in Canada to treat pain caused due to knee osteoarthritis. The launch of new and effective treatment options for managing this condition is likely to boost the knee osteoarthritis treatment market during the forecast period from 2018 to 2026.
Pre Book Knee Osteoarthritis Treatment Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=52047<ype=S
The global knee osteoarthritis treatment market can be segmented based on treatment type, end-user, and region. In terms of treatment type, the knee osteoarthritis treatment market can be classified into non-surgical treatment and surgical treatment. The non-surgical treatment segment is divided into drugs, alternate therapies, and others. Based on end-user, the knee osteoarthritis treatment market can be divided into hospitals, ambulatory surgical centers, and specialty clinics.
In terms of region, the global knee osteoarthritis treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market due to the launch of new treatment options in the region. The market in Asia Pacific is projected to expand during the forecast owing to the increase in geriatric population in the region.
Key players operating in the global knee osteoarthritis treatment market include Bioventus, AVM Biotechnology, Anika Therapeutics, Inc, Flexion Therapeutics, and OrthoTrophix, Inc.
Browse more Reports by Transparency Market Research:
Regulatory Affairs Outsourcing Market: Companies aspiring to widen their global reach are increasing investments on R&D activities and new products are entering clinical trials and the market at a rapid pace. Undertaking regulatory affairs and the maintenance of vast volumes data generated during the process can be a daunting task for companies having a vast product portfolio and operations spread across diverse regional markets.
Pharmaceutical Robots Market: The global pharmaceutical robots market is expanding at a rapid pace owing to increase in penetration of robotics in the pharmaceutical sector, technological advancements, and minimization of production cost due to automation. Pharmaceutical robots are adept at performing tasks at rates that far exceed human capability.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/